首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): study protocol for a phase III multi-centre double-masked randomised controlled trial
【2h】

Adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): study protocol for a phase III multi-centre double-masked randomised controlled trial

机译:眼球和眼周类固醇(醋酸曲安奈德)的辅助治疗与标准治疗在开腹创伤玻璃体视网膜手术(ASCOT)的眼睛中进行:III期多中心双掩蔽的随机对照试验研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundEyes sustaining open globe trauma are at high risk of severe visual impairment. Ocular injuries which result in visual loss invariably affect the posterior segment of the eye, and prevention of visual loss involves posterior segment (vitreoretinal) surgery. Despite improvements in vitreoretinal surgical techniques, outcomes in these patients remain unsatisfactory, and development of the intraocular scarring response proliferative vitreoretinopathy is the leading cause. Proliferative vitreoretinopathy is the most common cause of recurrent retinal detachment in these eyes; it is reported to occur in up to 45 % of cases.
机译:背景遭受开放性眼外伤的眼睛处于严重视力损害的高风险中。导致视力丧失的眼外伤总是影响眼睛的后段,而预防视力下降则涉及后段(玻璃体视网膜)手术。尽管玻璃体视网膜手术技术有所改善,但这些患者的预后仍不令人满意,并且眼内瘢痕反应的发展是增生性玻璃体视网膜病变的主要原因。增生性玻璃体视网膜病变是这些眼睛复发性视网膜脱离的最常见原因。据报道它的发生率高达45%。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号